<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9108409" created="07/06/28" creator="Yumiko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9108409</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Two distinct pathways of <term id="T1" lex="interleukin-5_synthesis" sem="Other"><term id="T2" lex="interleukin-5" sem="Protein_molecule">interleukin-5</term> synthesis</term> in <term id="T3" lex="allergen-specific_human_T-cell_clone" sem="Cell_cultured">allergen-specific human T-cell clones</term> are suppressed by <term id="T4" lex="glucocorticoid" sem="Lipid">glucocorticoids</term>.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="T2"/>
<clue>Two distinct pathways of interleukin-5 <clueType>synthesis</clueType> <clueLoc>in allergen-specific human T-cell clones</clueLoc> are suppressed by glucocorticoids.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="T4"/>
<clue>Two distinct pathways of interleukin-5 synthesis <clueLoc>in allergen-specific human T-cell clones</clueLoc> are <clueType>suppressed</clueType> <linkCause>by</linkCause> glucocorticoids.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T5" lex="glucocorticoid" sem="Lipid">Glucocorticoids</term> (<term id="T6" lex="GC" sem="Lipid">GC</term>) have long been used as the most effective agents for the treatment of <term id="T7" lex="allergic_disease" sem="Other">allergic diseases</term> accompanied by <term id="T8" lex="eosinophilia" sem="Other">eosinophilia</term> such as <term id="T9" lex="chronic_asthma" sem="Other">chronic asthma</term> and <term id="T10" lex="atopic_dermatitis" sem="Other">atopic dermatitis</term>.</sentence>
<event KT="Fact" Manner="High" id="E5">
<type class="Regulation"/>
<theme idref="T7"/>
<cause idref="T6"/>
<clue>Glucocorticoids (GC) have long been used as <clueManner>the most</clueManner> <clueType><clueManner>effective</clueManner> agents</clueType> <linkTheme>for</linkTheme> the treatment of allergic diseases accompanied by eosinophilia such as chronic asthma and atopic dermatitis.</clue>
</event>
<event KT="Other" id="E3">
<type class="Regulation"/>
<theme idref="T7"/>
<cause idref="T9"/>
<clue>Glucocorticoids (GC) have long been used as the most effective agents for the treatment of allergic diseases <clueType>accompanied</clueType> <linkCause>by</linkCause> <corefCause>eosinophilia</corefCause> such as chronic asthma and atopic dermatitis.</clue>
</event>
<event KT="Other" id="E4">
<type class="Regulation"/>
<theme idref="T7"/>
<cause idref="T10"/>
<clue>Glucocorticoids (GC) have long been used as the most effective agents for the treatment of allergic diseases <clueType>accompanied</clueType> <linkCause>by</linkCause> <corefCause>eosinophilia</corefCause> such as chronic asthma and atopic dermatitis.</clue>
</event>
<sentence id="S3">The development of <term id="T11" lex="chronic_eosinophilic_inflammation" sem="Other">chronic eosinophilic inflammation</term> is dependent on <term id="T12" lex="interleukin-5" sem="Protein_molecule">interleukin-5</term> (<term id="T13" lex="IL-5" sem="Protein_molecule">IL-5</term>), a <term id="T14" lex="selective_eosinophil-activating_factor" sem="Protein_family_or_group">selective eosinophil-activating factor</term>, produced by <term id="T15" lex="helper_T_cell" sem="Cell_natural">helper T cells</term>.</sentence>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<clue>The <clueType>development</clueType> <linkTheme>of</linkTheme> chronic eosinophilic inflammation is dependent on interleukin-5 (IL-5), a selective eosinophil-activating factor, produced by helper T cells.</clue>
</event>
<event KT="Fact" id="E7">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="T13"/>
<clue>The development of chronic eosinophilic inflammation is <clueType>dependent</clueType> <linkCause>on</linkCause> interleukin-5 (IL-5), a selective eosinophil-activating factor, produced by helper T cells.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Gene_expression"/>
<theme idref="T13"/>
<clue>The development of chronic eosinophilic inflammation is dependent on interleukin-5 (IL-5), a selective eosinophil-activating factor, <clueType>produced</clueType> <clueLoc>by helper T cells</clueLoc>.</clue>
</event>
<sentence id="S4">To delineate the regulatory mechanisms of <term id="T16" lex="human_IL-5_synthesis" sem="Other">human <term id="T17" lex="IL-5" sem="Protein_molecule">IL-5</term> synthesis</term>, we established <term id="T18" lex="allergen-specific_CD4+_T-cell_clone" sem="Cell_cultured">allergen-specific CD4+ T-cell clones</term> from <term id="T19" lex="asthmatic_patient" sem="Multicellular_organism_natural">asthmatic patients</term>.</sentence>
<event KT="Other" id="E9">
<type class="Gene_expression"/>
<theme idref="T17"/>
<clue>To delineate the regulatory mechanisms of human IL-5 <clueType>synthesis</clueType>, we established <clueLoc>allergen-specific CD4+ T-cell clones from asthmatic patients</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E10" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E9"/>
<clue><clueKT>To delineate</clueKT> the <clueType>regulatory</clueType> mechanisms <linkTheme>of</linkTheme> human IL-5 synthesis, we established <clueLoc>allergen-specific CD4+ T-cell clones from asthmatic patients</clueLoc>.</clue>
</event>
<sentence id="S5"><term id="T20" lex="GC" sem="Lipid">GC</term> efficiently suppressed <term id="T21" lex="IL-5_synthesis" sem="Other"><term id="T22" lex="IL-5" sem="Protein_molecule">IL-5</term> synthesis</term> of <term id="A8" sem="Cell_cultured">T-cell clones</term> activated via either <term id="T23" lex="T-cell_receptor" sem="Protein_family_or_group">T-cell receptor</term> (<term id="T24" lex="TCR" sem="Protein_family_or_group">TCR</term>) or <term id="T25" lex="IL-2_receptor" sem="Protein_molecule">IL-2 receptor</term> (<term id="T26" lex="IL-2R" sem="Protein_molecule">IL-2R</term>).</sentence>
<event KT="Other" id="E11">
<type class="Gene_expression"/>
<theme idref="T22"/>
<clue>GC efficiently suppressed IL-5 <clueType>synthesis</clueType> <clueLoc>of T-cell clones</clueLoc> activated via either T-cell receptor (TCR) or IL-2 receptor (IL-2R).</clue>
</event>
<event id="E12">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="T20"/>
<clue>GC efficiently <clueType>suppressed</clueType> IL-5 synthesis <clueLoc>of T-cell clones</clueLoc> activated via either T-cell receptor (TCR) or IL-2 receptor (IL-2R).</clue>
</event>
<event id="E13">
<type class="Physiological_process"/>
<theme idref="A8"/>
<cause idref="T24"/>
<clue>GC efficiently suppressed IL-5 synthesis of T-cell clones <clueType>activated</clueType> <linkCause>via</linkCause> either T-cell receptor (TCR) or IL-2 receptor (IL-2R).</clue>
</event>
<event id="E14">
<type class="Physiological_process"/>
<theme idref="A8"/>
<cause idref="T26"/>
<clue>GC efficiently suppressed IL-5 synthesis of T-cell clones <clueType>activated</clueType> <linkCause>via</linkCause> either T-cell receptor (TCR) or IL-2 receptor (IL-2R).</clue>
</event>
<sentence id="S6">Induction of <term id="T27" lex="IL-5_mRNA" sem="RNA_molecule"><term id="T28" lex="IL-5" sem="Protein_molecule">IL-5</term> mRNA</term> upon <term id="T29" lex="TCR" sem="Protein_family_or_group">TCR</term> and <term id="T30" lex="IL-2R_stimulation" sem="Other"><term id="T31" lex="IL-2R" sem="Protein_molecule">IL-2R</term> stimulation</term> was totally inhibited by <term id="T32" lex="dexamethasone" sem="Lipid">dexamethasone</term>.</sentence>
<event KT="Other" id="E15">
<type class="Transcription"/>
<theme idref="T28"/>
<clue>Induction of IL-5 <clueType>mRNA</clueType> upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.</clue>
</event>
<event KT="Other" id="E16">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="E20"/>
<clue><clueType>Induction</clueType> <linkTheme>of</linkTheme> IL-5 mRNA <linkCause>upon</linkCause> TCR and IL-2R stimulation was totally inhibited by dexamethasone.</clue>
</event>
<event KT="Other" id="E17">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="E21"/>
<clue><clueType>Induction</clueType> <linkTheme>of</linkTheme> IL-5 mRNA <linkCause>upon</linkCause> TCR and IL-2R stimulation was totally inhibited by dexamethasone.</clue>
</event>
<event Manner="High" id="E18">
<type class="Negative_regulation"/>
<theme idref="E16"/>
<cause idref="T32"/>
<clue>Induction of IL-5 mRNA upon TCR and IL-2R stimulation was <clueManner>totally</clueManner> <clueType>inhibited</clueType> <linkCause>by</linkCause> dexamethasone.</clue>
</event>
<event Manner="High" id="E19">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="T32"/>
<clue>Induction of IL-5 mRNA upon TCR and IL-2R stimulation was <clueManner>totally</clueManner> <clueType>inhibited</clueType> <linkCause>by</linkCause> dexamethasone.</clue>
</event>
<event id="E20">
<type class="Positive_regulation"/>
<cause idref="T29"/>
<clue>Induction of IL-5 mRNA upon TCR and IL-2R <clueType>stimulation</clueType> was totally inhibited by dexamethasone.</clue>
<comment>NO THEME</comment></event>
<event id="E21">
<type class="Positive_regulation"/>
<cause idref="T31"/>
<clue>Induction of IL-5 mRNA upon TCR and IL-2R <clueType>stimulation</clueType> was totally inhibited by dexamethasone.</clue>
<comment>NO THEME</comment></event>
<sentence id="S7">Human <term id="A2" sem="DNA_domain_or_region"><term id="T33" lex="IL-5" sem="Protein_molecule">IL-5</term> promoter/enhancer-luciferase gene construct</term> transfected to <term id="T34" lex="T-cell_clone" sem="Cell_cultured">T-cell clones</term> was transcribed on either <term id="T35" lex="TCR" sem="Protein_family_or_group">TCR</term> or <term id="T36" lex="IL-2R_stimulation" sem="Other"><term id="T37" lex="IL-2R" sem="Protein_molecule">IL-2R</term> stimulation</term> and was clearly downregulated by <term id="T38" lex="dexamethasone" sem="Lipid">dexamethasone</term>, indicating that the approximately <term id="T39" lex="500-bp_human_IL-5_gene_segment" sem="DNA_domain_or_region">500-bp human <term id="T40" lex="IL-5" sem="Protein_molecule">IL-5</term> gene segment</term> located <term id="T41" lex="5&apos;_upstream" sem="DNA_domain_or_region">5&apos; upstream</term> of the coding region contains <term id="T42" lex="activation-inducible_enhancer_element" sem="DNA_family_or_group"><term id="A1" sem="Other">activation</term>-inducible <term id="A6" sem="DNA_domain_or_region">enhancer elements</term></term> responsible for the regulation by <term id="T43" lex="GC" sem="Lipid">GC</term>.</sentence>
<event KT="Method" id="E22">
<type class="Artificial_process"/>
<theme idref="A2"/>
<theme idref="T34"/>
<clue>Human IL-5 promoter/enhancer-luciferase gene construct <clueType>transfected</clueType> <linkTheme>to</linkTheme> T-cell clones was transcribed on either TCR or IL-2R stimulation and was clearly downregulated by dexamethasone, indicating that the approximately 500-bp human IL-5 gene segment located 5&apos; upstream of the coding region contains activation-inducible enhancer elements responsible for the regulation by GC.</clue>
</event>
<event id="E24">
<type class="Transcription"/>
<theme idref="A2"/>
<clue>Human IL-5 promoter/enhancer-luciferase gene construct transfected to T-cell clones was <clueType>transcribed</clueType> on either TCR or IL-2R stimulation and was clearly downregulated by dexamethasone, indicating that the approximately 500-bp human IL-5 gene segment located 5&apos; upstream of the coding region contains activation-inducible enhancer elements responsible for the regulation by GC.</clue>
</event>
<event id="E28">
<type class="Regulation"/>
<theme idref="E24"/>
<cause idref="T35"/>
<clue>Human IL-5 promoter/enhancer-luciferase gene construct transfected to T-cell clones was transcribed <linkCause>on</linkCause> either TCR or IL-2R <clueType>stimulation</clueType> and was clearly downregulated by dexamethasone, indicating that the approximately 500-bp human IL-5 gene segment located 5&apos; upstream of the coding region contains activation-inducible enhancer elements responsible for the regulation by GC.</clue>
</event>
<event id="E30">
<type class="Regulation"/>
<theme idref="E24"/>
<cause idref="T37"/>
<clue>Human IL-5 promoter/enhancer-luciferase gene construct transfected to T-cell clones was transcribed <linkCause>on</linkCause> either TCR or IL-2R <clueType>stimulation</clueType> and was clearly downregulated by dexamethasone, indicating that the approximately 500-bp human IL-5 gene segment located 5&apos; upstream of the coding region contains activation-inducible enhancer elements responsible for the regulation by GC.</clue>
</event>
<event id="E32">
<type class="Negative_regulation"/>
<theme idref="A2"/>
<cause idref="T38"/>
<clue>Human IL-5 promoter/enhancer-luciferase gene construct transfected to T-cell clones was transcribed on either TCR or IL-2R stimulation and was clearly <clueType>downregulated</clueType> <linkCause>by</linkCause> dexamethasone, indicating that the approximately 500-bp human IL-5 gene segment located 5&apos; upstream of the coding region contains activation-inducible enhancer elements responsible for the regulation by GC.</clue>
</event>
<event KT="Other" id="E34">
<type class="Positive_regulation"/>
<theme idref="A1"/>
<cause idref="A6"/>
<clue>Human IL-5 promoter/enhancer-luciferase gene construct transfected to T-cell clones was transcribed on either TCR or IL-2R stimulation and was clearly downregulated by dexamethasone, indicating that the approximately 500-bp human IL-5 gene segment located 5&apos; upstream of the coding region contains activation-<clueType>inducible</clueType> enhancer elements responsible for the regulation by GC.</clue>
</event>
<event KT="Other" id="E35">
<type class="Regulation"/>
<cause idref="T43"/>
<clue>Human IL-5 promoter/enhancer-luciferase gene construct transfected to T-cell clones was transcribed on either TCR or IL-2R stimulation and was clearly downregulated by dexamethasone, indicating that the approximately 500-bp human IL-5 gene segment located 5&apos; upstream of the coding region contains activation-inducible enhancer elements responsible for the <clueType>regulation</clueType> <linkCause>by</linkCause> GC.</clue>
<comment>NO THEME</comment></event>
<event CL="L2" KT="Analysis" id="E36">
<type class="Regulation"/>
<theme idref="E35"/>
<cause idref="A6"/>
<clue>Human IL-5 promoter/enhancer-luciferase gene construct transfected to T-cell clones was transcribed on either TCR or IL-2R stimulation and was clearly downregulated by dexamethasone, <clueKT><clueCL>indicating</clueCL></clueKT> that the approximately 500-bp human IL-5 gene segment located 5&apos; upstream of the coding region contains activation-inducible enhancer elements <clueType>responsible</clueType> <linkTheme>for</linkTheme> the regulation by GC.</clue>
</event>
<sentence id="S8"><term id="T44" lex="electrophoretic_mobility_shift_assay_analysis" sem="Other">Electrophoretic mobility shift assay analysis</term> suggested that <term id="T45" lex="AP-1" sem="Protein_molecule">AP-1</term> and <term id="T46" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> are among the possible targets of <term id="T47" lex="GC_action" sem="Other"><term id="T48" lex="GC" sem="Lipid">GC</term> actions</term> on <term id="T49" lex="TCR-stimulated_T_cell" sem="Cell_natural"><term id="T50" lex="TCR" sem="Protein_family_or_group">TCR</term>-stimulated <term id="A7" sem="Cell_natural">T cells</term></term>.</sentence>
<event KT="Other" id="E37">
<type class="Physiological_process"/>
<theme idref="A7"/>
<cause idref="T50"/>
<clue>Electrophoretic mobility shift assay analysis suggested that AP-1 and NF-kappaB are among the possible targets of GC actions on TCR-<clueType>stimulated</clueType> T cells.</clue>
</event>
<event CL="L1" KT="Analysis" id="E23" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T45"/>
<cause idref="T48"/>
<clue><clueExperiment>Electrophoretic mobility shift assay analysis</clueExperiment> <clueKT>suggested</clueKT> that AP-1 and NF-kappaB are among the <clueCL>possible</clueCL> <clueType>targets</clueType> <linkCause>of</linkCause> GC actions <clueLoc>on TCR-stimulated T cells</clueLoc>.</clue>
</event>
<event CL="L1" KT="Analysis" id="E25" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T46"/>
<cause idref="T48"/>
<clue><clueExperiment>Electrophoretic mobility shift assay analysis</clueExperiment> <clueKT>suggested</clueKT> that AP-1 and NF-kappaB are among the <clueCL>possible</clueCL> <clueType>targets</clueType> <linkCause>of</linkCause> GC actions <clueLoc>on TCR-stimulated T cells</clueLoc>.</clue>
</event>
<sentence id="S9"><term id="T51" lex="NF-AT" sem="Protein_molecule">NF-AT</term> and <term id="T52" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> were not significantly induced by <term id="T53" lex="IL-2_stimulation" sem="Other"><term id="T54" lex="IL-2" sem="Protein_molecule">IL-2</term> stimulation</term>.</sentence>
<event Manner="High" Polarity="Negative" assertion="non-exist" id="E38">
<type class="Positive_regulation"/>
<theme idref="T51"/>
<cause idref="T54"/>
<clue>NF-AT and NF-kappaB were <cluePolarity>not</cluePolarity> <clueManner>significantly</clueManner> <clueType>induced</clueType> <linkCause>by</linkCause> IL-2 stimulation.</clue>
</event>
<event Manner="High" Polarity="Negative" assertion="non-exist" id="E39">
<type class="Positive_regulation"/>
<theme idref="T52"/>
<cause idref="T54"/>
<clue>NF-AT and NF-kappaB were <cluePolarity>not</cluePolarity> <clueManner>significantly</clueManner> <clueType>induced</clueType> <linkCause>by</linkCause> IL-2 stimulation.</clue>
</event>
<sentence id="S10">Our results showing that <term id="T55" lex="GC" sem="Lipid">GC</term> suppressed <term id="T56" lex="IL-5" sem="Protein_molecule">IL-5</term> production by <term id="T57" lex="human_CD4+_T_cell" sem="Cell_natural">human <term id="A9" sem="Cell_natural">CD4+ T cells</term></term> activated by two distinct stimuli, <term id="T58" lex="TCR" sem="Protein_family_or_group">TCR</term> and <term id="T59" lex="IL-2R_stimulation" sem="Other"><term id="T60" lex="IL-2R" sem="Protein_molecule">IL-2R</term> stimulation</term>, underscore the efficacy of <term id="T61" lex="GC" sem="Lipid">GC</term> in the treatment of <term id="T62" lex="allergic_disease" sem="Other">allergic diseases</term> via suppression of <term id="T63" lex="T-cell_IL-5_synthesis" sem="Other">T-cell <term id="T64" lex="IL-5" sem="Protein_molecule">IL-5</term> synthesis</term>.</sentence>
<event KT="Other" id="E40">
<type class="Gene_expression"/>
<theme idref="T56"/>
<clue>Our results showing that GC suppressed IL-5 <clueType>production</clueType> <clueLoc>by human CD4+ T cells activated by two distinct stimuli, TCR and IL-2R stimulation</clueLoc>, underscore the efficacy of GC in the treatment of allergic diseases via suppression of T-cell IL-5 synthesis.</clue>
</event>
<event KT="Analysis" id="E41">
<type class="Negative_regulation"/>
<theme idref="E40"/>
<cause idref="T55"/>
<clue>Our results <clueKT>showing</clueKT> that GC <clueType>suppressed</clueType> IL-5 production <clueLoc>by human CD4+ T cells activated by two distinct stimuli, TCR and IL-2R stimulation</clueLoc>, underscore the efficacy of GC in the treatment of allergic diseases via suppression of T-cell IL-5 synthesis.</clue>
</event>
<event KT="Other" id="E42">
<type class="Physiological_process"/>
<theme idref="A9"/>
<cause idref="T58"/>
<clue>Our results showing that GC suppressed IL-5 production by human CD4+ T cells <clueType>activated</clueType> <linkCause>by</linkCause> two distinct stimuli, TCR and IL-2R stimulation, underscore the efficacy of GC in the treatment of allergic diseases via suppression of T-cell IL-5 synthesis.</clue>
</event>
<event KT="Other" id="E43">
<type class="Physiological_process"/>
<theme idref="A9"/>
<cause idref="T60"/>
<clue>Our results showing that GC suppressed IL-5 production by human CD4+ T cells <clueType>activated</clueType> <linkCause>by</linkCause> two distinct stimuli, TCR and IL-2R stimulation, underscore the efficacy of GC in the treatment of allergic diseases via suppression of T-cell IL-5 synthesis.</clue>
</event>
<event KT="Analysis" id="E44">
<type class="Regulation"/>
<theme idref="E47"/>
<cause idref="T61"/>
<clue>Our results showing that GC suppressed IL-5 production by human CD4+ T cells activated by two distinct stimuli, TCR and IL-2R stimulation, <clueKT>underscore</clueKT> the <clueType>efficacy</clueType> <linkCause>of</linkCause> GC in the treatment of allergic diseases <linkTheme>via</linkTheme> suppression of T-cell IL-5 synthesis.</clue>
</event>
<event KT="Other" id="E45">
<type class="Regulation"/>
<theme idref="T62"/>
<cause idref="E47"/>
<clue>Our results showing that GC suppressed IL-5 production by human CD4+ T cells activated by two distinct stimuli, TCR and IL-2R stimulation, underscore the efficacy of GC in the treatment of allergic diseases <linkCause>via</linkCause> suppression of T-cell IL-5 synthesis.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Other" id="E46">
<type class="Gene_expression"/>
<theme idref="T64"/>
<clue>Our results showing that GC suppressed IL-5 production by human CD4+ T cells activated by two distinct stimuli, TCR and IL-2R stimulation, underscore the efficacy of GC in the treatment of allergic diseases via suppression of <clueLoc>T-cell</clueLoc> IL-5 <clueType>synthesis</clueType>.</clue>
</event>
<event KT="Other" id="E47">
<type class="Negative_regulation"/>
<theme idref="E46"/>
<clue>Our results showing that GC suppressed IL-5 production by human CD4+ T cells activated by two distinct stimuli, TCR and IL-2R stimulation, underscore the efficacy of GC in the treatment of allergic diseases via <clueType>suppression</clueType> <linkTheme>of</linkTheme> <clueLoc>T-cell</clueLoc> IL-5 synthesis.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
